The clinical drug candidate anle138b binds in a cavity of lipidic α-synuclein fibrils.Published in:Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-32797-wBy:Antonschmidt, Leif;Matthes, Dirk;Dervişoğlu, Rıza;Frieg, Benedikt;Dienemann, Christian;Leonov, Andrei;Nimerovsky, Evgeny;Sant, Vrinda;Ryazanov, Sergey;Giese, Armin;Schröder, Gunnar F.;Becker, Stefan;de Groot, Bert L.;Griesinger, Christian;Andreas, Loren B.Publication type:Article